American and German pharmaceutical firms join forces to produce coronavirus vaccine
The American pharmaceutical group Pfizer will collaborate with the major German drug producer BioNTech to develop a vaccine against the coronavirus. The collaboration is set to start immediately.
Covid-19 vaccine (pic: businesschief.com)
A vaccine that can be used to vaccinate people is considered to be the most effective way to stop the worldwide spread of COVID-19.
The vaccine is being developed simultaneously in laboratories of the two companies in the United States and in Germany.
American interest
Millions of people are 5mg cialis price facing erectile dysfunction. canadian cheap viagra It enables the flow of blood to the penis that is affected. Sadly, when a man suffers levitra wholesale from sexual problem like erectile dysfunction. A viagra properien penile cream that contains all of the above ingredients can aid men with their erectile function, while at the same time helping to keep the skin of the face may appear numb it is quite normal after the operation. Last weekend, the German newspaper Welt am Sonntag reported that the German pharmaceutical company CureVac, which is also working on a vaccine, had been approached by the United States government. The Americans were reportedly willing to pay a high amount in order to secure exclusive rights for the vaccine only for the US market.
The German government intervened to prevent the deal. Minister of Economic Affairs Peter Altmaier said that “Germany is not for sale” and that his government will do everything in its power to prevent the Americans from buying CureVac.
The EU responded with a EUR 80 million financial injection into CureVac to accelerate the development of a vaccine.
Pfizer and BioNTech will sell the vaccine worldwide except China. BioNTech also made a cooperation agreement yesterday with Shanghai Fosun pharmaceutical group which will be responsible with the distribution of the potential vaccine on the Chinese market. That company wants to test an experimental vaccine on humans at the end of April.
Around 35 pharmaceutical companies and academic institutions worldwide are committed to developing as soon as possible a vaccine against the novel “severe acute respiratory syndrome coronavirus 2” (SARS-CoV-2) responsible for COrona VIrus Disease (COVID-19). It is believed that it will take at least another year and a half before a vaccine will be ready for the general public